Atlas Trials

Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers

Clinical trial NCT03337516 · UNKNOWN

Trial details

NCT number
NCT03337516
Sponsor
Assistance Publique Hopitaux De Marseille
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2017-06-21
Primary completion
2017-12-21
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.